C
NexgenRx Inc. NXG.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income 212.21% 464.06% 137.27% -5.71% -96.97%
Total Depreciation and Amortization -5.41% -5.99% -3.19% -5.79% -3.73%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -83.02% 7.87% -39.22% -58.57% -135.81%
Change in Net Operating Assets -158.76% 109.59% -34.89% 152.93% -49.46%
Cash from Operations -81.62% 56.84% -18.44% 181.96% -46.55%
Capital Expenditure 85.89% -435.71% -191.49% -103.57% 91.58%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- 26.59% -- 100.00% --
Cash from Investing -24.18% 11.85% -855.32% -103.73% 91.91%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -53.18% -39.31% -19.65% -1.49% 42.72%
Issuance of Common Stock 0.00% -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid 1.63% 8.88% -0.41% -1,166.26% 92.31%
Other Financing Activities -- -- -- -- --
Cash from Financing -341.76% 14.52% 242.20% -643.31% 102.65%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -94.84% 8,305.13% -2.93% 73.39% 221.93%
Weiss Ratings